|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable, net of allowance of $10,720 as of June 30, 2026 and $12,527 as of December 31, 2025 | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Prepaid and refundable taxes | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Property, plant, and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Operating lease assets | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Long-term derivative assets | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Current debt obligations | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities and other | ||||||||||||||||||||
| Current derivative liabilities | ||||||||||||||||||||
| SNIA environmental liability | ||||||||||||||||||||
| Current contingent consideration | ||||||||||||||||||||
| Current litigation provision liability | ||||||||||||||||||||
| Taxes payable | ||||||||||||||||||||
| Accrued employee compensation and related benefits | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Long-term debt obligations | ||||||||||||||||||||
| Contingent consideration | ||||||||||||||||||||
| Long-term contingent consideration | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Long-term operating lease liabilities | ||||||||||||||||||||
| Long-term employee compensation and related benefits | ||||||||||||||||||||
| Long-term derivative liabilities | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Shareholders’ Equity: | ||||||||||||||||||||
| Ordinary Shares, £1.00 par value: Unlimited shares authorized; 55,601,145 shares issued and 55,051,768 shares outstanding as of June 30, 2026; 55,535,181 shares issued and 54,649,085 shares outstanding as of December 31, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive (loss) income | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Treasury shares at cost, 549,377 ordinary shares as of June 30, 2026; 886,096 ordinary shares as of December 31, 2025 | ||||||||||||||||||||
| Total Shareholders’ Equity | ||||||||||||||||||||
| Total Liabilities and Shareholders’ Equity | ||||||||||||||||||||
Loading...
